[go: up one dir, main page]

GB0104696D0 - Degradation of tse and similar agents - Google Patents

Degradation of tse and similar agents

Info

Publication number
GB0104696D0
GB0104696D0 GB0104696A GB0104696A GB0104696D0 GB 0104696 D0 GB0104696 D0 GB 0104696D0 GB 0104696 A GB0104696 A GB 0104696A GB 0104696 A GB0104696 A GB 0104696A GB 0104696 D0 GB0104696 D0 GB 0104696D0
Authority
GB
United Kingdom
Prior art keywords
tse
degradation
similar agents
agents
similar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0104696A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Public Health England
Original Assignee
Microbiological Research Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbiological Research Authority filed Critical Microbiological Research Authority
Priority to GB0104696A priority Critical patent/GB0104696D0/en
Publication of GB0104696D0 publication Critical patent/GB0104696D0/en
Priority to DE60203599T priority patent/DE60203599T2/en
Priority to AT02726996T priority patent/ATE292679T1/en
Priority to EP02726996A priority patent/EP1360282B1/en
Priority to PCT/GB2002/000052 priority patent/WO2002053723A2/en
Priority to PT02726996T priority patent/PT1360282E/en
Priority to CA002434129A priority patent/CA2434129A1/en
Priority to ES02726996T priority patent/ES2237675T3/en
Priority to EP04025721A priority patent/EP1577382A3/en
Priority to AU2002219336A priority patent/AU2002219336C1/en
Priority to DK02726996T priority patent/DK1360282T3/en
Priority to JP2002555233A priority patent/JP4427252B2/en
Priority to US10/614,370 priority patent/US7303907B2/en
Priority to HK03109416A priority patent/HK1057062A1/en
Priority to US11/871,087 priority patent/US8110391B2/en
Priority to JP2008068993A priority patent/JP4427587B2/en
Ceased legal-status Critical Current

Links

GB0104696A 2001-01-08 2001-02-26 Degradation of tse and similar agents Ceased GB0104696D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB0104696A GB0104696D0 (en) 2001-02-26 2001-02-26 Degradation of tse and similar agents
JP2002555233A JP4427252B2 (en) 2001-01-08 2002-01-08 Reduction and detection of TSE infectivity
CA002434129A CA2434129A1 (en) 2001-01-08 2002-01-08 Degradation and detection of prion infectivity
EP04025721A EP1577382A3 (en) 2001-01-08 2002-01-08 Detection of TSE infectivity
EP02726996A EP1360282B1 (en) 2001-01-08 2002-01-08 Method for inactivation of TSE
PCT/GB2002/000052 WO2002053723A2 (en) 2001-01-08 2002-01-08 Degradation and detection of tse infectivity
PT02726996T PT1360282E (en) 2001-01-08 2002-01-08 METHOD OF INACTIVATION OF TSE
DE60203599T DE60203599T2 (en) 2001-01-08 2002-01-08 Method for inactivating TSE
ES02726996T ES2237675T3 (en) 2001-01-08 2002-01-08 METHOD FOR THE INACTIVATION OF THE TSE.
AT02726996T ATE292679T1 (en) 2001-01-08 2002-01-08 METHOD FOR INACTIVATION OF TSE
AU2002219336A AU2002219336C1 (en) 2001-01-08 2002-01-08 Degradation and detection of TSE infectivity
DK02726996T DK1360282T3 (en) 2001-01-08 2002-01-08 Method of inactivating TSE
US10/614,370 US7303907B2 (en) 2001-01-08 2003-07-08 Degradation and detection of TSE infectivity
HK03109416A HK1057062A1 (en) 2001-01-08 2003-12-27 Method for inactivation of tse.
US11/871,087 US8110391B2 (en) 2001-01-08 2007-10-11 Degradation and detection of TSE infectivity
JP2008068993A JP4427587B2 (en) 2001-01-08 2008-03-18 Detection of TSE infectivity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0104696A GB0104696D0 (en) 2001-02-26 2001-02-26 Degradation of tse and similar agents

Publications (1)

Publication Number Publication Date
GB0104696D0 true GB0104696D0 (en) 2001-04-11

Family

ID=9909515

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0104696A Ceased GB0104696D0 (en) 2001-01-08 2001-02-26 Degradation of tse and similar agents

Country Status (1)

Country Link
GB (1) GB0104696D0 (en)

Similar Documents

Publication Publication Date Title
HUS000505I2 (en) Combination of thiencarbazone-methyl and mefenpyr-diethyl
GB0111872D0 (en) Therapeutic agents and methods
AU2002357119A8 (en) Mitocidal compositions and methods
IL161384A0 (en) Bicyclic oxopyridine and oxopyrimidine derivatives
AU6118001A (en) Combination therapeutic compositions and methods of use
HRP20031000A2 (en) Benzoylsulfonamides and sulfonylbenzamidines as antitumour agents
EP1474445A4 (en) Glycoisoforms of adiponectin and uses thereof
HU229606B1 (en) Novel combination of loteprednol and antihistamines
AU2002359512A8 (en) Belts and methods of use thereof
HK1068555A1 (en) New formulations and use thereof
GB0114014D0 (en) Compostion and use
IL154553A0 (en) Urocortin-iii and uses thereof
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2002357748A8 (en) Osteopontin-related compositions and methods
IL151589A0 (en) New combination of a betablocker and a cholestrol-lowering agent
PL368321A1 (en) Use of cystathionine
GB0105613D0 (en) Pharmaceutically effective compounds and their use
EP1392317A4 (en) Substituted 1-benzazepines and derivatives thereof
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
EP1511753A4 (en) Antimicrobial agents and uses thereof
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
HUP0304092A3 (en) Combination of active agents with bioregulatory effect and use thereof
EP1404670A4 (en) Semicarbazides and their uses
SI1372652T1 (en) Combination of docetaxel and flavopiridol
HUP0401162A3 (en) Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)
COOA Change in applicant's name or ownership of the application

Owner name: HEALTH PROTECTION AGENCY

Free format text: FORMER APPLICANT(S): MICROBIOLOGICAL RESEARCH AUTHORITY